FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for the fixed-dose combination of amlodipine and atorvastatin, with Prasco Laboratories listed as the applicant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• Amlodipine Besylate and Atorvastatin Calcium (amlodipine besylate and atorvastatin calcium)

Snippet

SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)